The total market value of menstrual cramps treatmentmarket is $560.8 million in 2021.
The market value of menstrual cramps treatment market in 2031 is $841.57 million
The base year is 2021 in menstrual cramps treatment market.
The forecast period for menstrual cramps treatment market is 2022 to 2031
Primary dysmenorrhea segment is the most influencing segment in menstrual cramps treatmnet market which is attributed to rise in prevalence of primary dysmenorrhea due to rise in depression and anxiety in women.
The major factor that fuels the growth of the menstrual cramps treatment market are rise in cases of menstrual pain in women and growing awareness of menstrual cramps treatment.
Top companies such as AbbVie Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., and Pfizer Inc. held a high market position in 2021. These key players held a high market postion owing to the strong geographical foothold in different regions.
Asia-Pacific has the highest growth rate in the market with highest CAGR of 4.8%. This is due to increase in health awareness among women and rise in number of hospitals equipped with advanced medical facilities.
Loading Table Of Content...
Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?